HEMABATE

This brand name is authorized in Canada, Hong Kong, Singapore, United Kingdom, United States

Active ingredients

The drug HEMABATE contains one active pharmaceutical ingredient (API):

1 Carboprost
UNII U4526F86FJ - CARBOPROST TROMETHAMINE

Carboprost is a synthetic 15-methyl analogue of dinoprost (prostaglandin F2 alpha). Administered intramuscularly carboprost stimulates in the gravid uterus myometrial contractions similar to labor contractions at the end of a full term pregnancy. It is indicated for aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and for the treatment of postpartum hemorrhage due to uterine atony, which has not responded to conventional methods of management. The most frequent adverse reactions observed are related to its contractile effect on smooth muscle: vomiting, diarrhea, nausea, fever and flushing. Carboprost may augment the activity of other oxytocic agents. Concomitant use with other oxytocic agents is not recommended.

Read about Carboprost

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
HEMABATE Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G02AD04 Carboprost G Genito urinary system and sex hormones → G02 Other gynecologicals → G02A Oxytocics → G02AD Prostaglandins
Discover more medicines within G02AD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02230417
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 48555
Country: HK Department of Health Drug Office Identifier(s): 34647
Country: SG Health Sciences Authority Identifier(s): 06722P
Country: US FDA, National Drug Code Identifier(s): 0009-0856

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.